Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
138 studies found for:    "Acromegaly"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
2 Completed Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
3 Approved for marketing An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide long acting release formulation
4 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Interventions: Procedure: Surgery for acromegaly;   Drug: Medications for acromegaly
5 Completed Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
6 Completed Surgical Versus Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention:
7 Completed Clomiphene Citrate for Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Clomiphene Citrate
8 Unknown  Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target
Condition: Acromegaly
Intervention: Drug: Sandostatin® LAR
9 Unknown  Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
10 Completed Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
Condition: Acromegaly
Intervention:
11 Unknown  A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
12 Unknown  Epidemiology of Acromegaly in Denmark 1991-2010
Condition: Acromegaly
Intervention:
13 Completed Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
Condition: Acromegaly
Intervention: Radiation: fractionated stereotactic radiotherapy
14 Recruiting Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
Condition: Acromegaly
Intervention: Drug: Pasireotide LAR
15 Recruiting Acromegaly & Sleep Apnoea
Condition: Acromegaly
Intervention:
16 Completed Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
17 Completed
Has Results
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide;   Drug: Octreotide
18 Recruiting Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide capsules;   Drug: Injectable Somatostatin Analogs (octreotide or lanreotide);   Drug: Cabergoline
19 Completed Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide LAR
20 Completed Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide-LAR or lanreotide;   Procedure: Transsphenoidal adenomectomy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.